|
|
 |
|
Viewing report
|
|
 |
 |
Chugai Pharmaceutical Co., Ltd. - Strategy and SWOT Report
Datamonitor, Oct 2011, Pages: 40
Chugai Pharmaceutical Co., Ltd. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Chugai Pharmaceutical Co., Ltd. required for business and competitor intelligence needs - A study of the major internal and external factors affecting Chugai Pharmaceutical Co., Ltd. in the form of a SWOT analysis - An in-depth view of the business model of Chugai Pharmaceutical Co., Ltd. including a breakdown and examination of key business segments - Intelligence on Chugai Pharmaceutical Co., Ltd.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Chugai Pharmaceutical Co., Ltd., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Chugai Pharmaceutical (Chugai), the Japanese subsidiary of the Roche Group, is engaged in biopharmaceutical research and development. It produces antibody drugs, focused in the three areas, oncology, renal diseases and bone and joint diseases. The company operates in Europe, Americas and Asia Pacific. It is headquartered in Tokyo, Japan and employed 6,709 people as of December 31, 2010. The company recorded revenues of JPY379,510 million (approximately $4,326.4 million) during the financial year ended December 2010 (FY2010), a decrease of 11.5% compared with FY2009. The operating profit of the company was JPY66,238 million (approximately $755.1 million) during FY2010, a decrease of 19.8% compared with FY2009. The net profit was JPY41,433 million (approximately $472.3 million) in FY2010, a decrease of 26.8% compared with FY2009.
Reasons to Purchase:
- Gain understanding of Chugai Pharmaceutical Co., Ltd. and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Chugai Pharmaceutical Co., Ltd. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Chugai Pharmaceutical Co., Ltd.’s business structure, strategy and prospects
|
 |
|
|